These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

733 related items for PubMed ID: 26646696

  • 1. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
    Sun G, Cheng YW, Lai L, Huang TC, Wang J, Wu X, Wang Y, Huang Y, Wang J, Zhang K, Hu S, Yang JR, Yen Y.
    Oncotarget; 2016 Jan 26; 7(4):3857-72. PubMed ID: 26646696
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G, Maciejewski R.
    Int J Cancer; 2013 Apr 01; 132(7):1633-45. PubMed ID: 22987275
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
    Chen Y, Zhang Y, He J, Fu Y, Lin C, Li X.
    Oncol Rep; 2017 Mar 01; 37(3):1646-1652. PubMed ID: 28098895
    [Abstract] [Full Text] [Related]

  • 4. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
    Wu X, Li S, Xu X, Wu S, Chen R, Jiang Q, Li Y, Xu Y.
    Int J Clin Exp Pathol; 2015 Mar 01; 8(3):2840-51. PubMed ID: 26045793
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression Analysis of Previously Verified Fecal and Plasma Dow-regulated MicroRNAs (miR-4478, 1295-3p, 142-3p and 26a-5p), in FFPE Tissue Samples of CRC Patients.
    Ghanbari R, Rezasoltani S, Hashemi J, Mohamadkhani A, Tahmasebifar A, Arefian E, Mobarra N, Asadi J, Nazemalhosseini Mojarad E, Yazdani Y, Knuutila S, Malekzadeh R.
    Arch Iran Med; 2017 Feb 01; 20(2):92-95. PubMed ID: 28193082
    [Abstract] [Full Text] [Related]

  • 7. Identification of microRNAs and their Endonucleolytic Cleavaged target mRNAs in colorectal cancer.
    Zhou F, Tang D, Xu Y, He H, Wu Y, Lin L, Dong J, Tan W, Dai Y.
    BMC Cancer; 2020 Mar 23; 20(1):242. PubMed ID: 32293320
    [Abstract] [Full Text] [Related]

  • 8. Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
    Wu X, Xu X, Li S, Wu S, Chen R, Jiang Q, Liu H, Sun Y, Li Y, Xu Y.
    PLoS One; 2015 Mar 23; 10(3):e0120024. PubMed ID: 25803870
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K, Toiyama Y, Schetter AJ, Okugawa Y, Harris CC, Boland CR, Goel A.
    J Natl Cancer Inst; 2015 Mar 23; 107(3):. PubMed ID: 25663689
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
    Chang PY, Chen CC, Chang YS, Tsai WS, You JF, Lin GP, Chen TW, Chen JS, Chan EC.
    Oncotarget; 2016 Mar 01; 7(9):10663-75. PubMed ID: 26848774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.